You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antigen presenting cells (APCs)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

Not yet recruiting
  • Metastatic Solid Tumor
  • TAC01-CLDN18.2
  • (no location specified)
May 8, 2023

COVID-19 Respiratory Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Pamplona (Nasal Photodisinfection, Sham

Completed
  • COVID-19 Respiratory Infection
  • SARS-CoV-2 Acute Respiratory Disease
  • Nasal Photodisinfection
  • Sham Comparator: Control
  • Pamplona, Spain
    Clinica Universidad de Navarra
Aug 10, 2022

Multiple Myeloma Trial in Beijing, Guangzhou, Shanghai (TQB2934 injection)

Not yet recruiting
  • Multiple Myeloma
  • TQB2934 injection
  • Beijing, Beijing, China
  • +2 more
Dec 8, 2022

Systemic Lupus Erythematosus (SLE) Trial in Shanghai (anti-CD19 CAR NK cells (KN5501))

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • anti-CD19 CAR NK cells (KN5501)
  • Shanghai, China
    Changhai Hospital
Aug 25, 2023

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Apr 5, 2023

    Multiple Myeloma Trial in Wuhan (Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells)

    Recruiting
    • Multiple Myeloma
    • Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Aug 11, 2023

    SLE (Systemic Lupus) Trial in Bangkok (CAR T-cell therapy)

    Not yet recruiting
    • SLE (Systemic Lupus)
    • CAR T-cell therapy
    • Bangkok, Please Select, Thailand
      King Chulalongkorn Memorial Hospital
    Nov 23, 2023

    Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

    Not yet recruiting
    • Recurrent Glioblastoma
    • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
    • (no location specified)
    Apr 4, 2023

    Diabetes, Type 1 Trial in Aurora (Methyldopa)

    Completed
    Has Results
    • Diabetes Mellitus, Type 1
    • Aurora, Colorado
      Barbara Davis Center for Diabetes, University of Colorado School
    Jan 6, 2022

    Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

    Recruiting
    • Brain Gliomas
    • Allogenic B7H3 CAR-γδT cell
    • Suzhou, Jiangsu, China
      Dushu Lake Hospital Affiliated to Soochow University
    Aug 25, 2023

    Malignant Pleural Effusion, Malignant Peritoneal Effusion Trial in Wuhan (Virus Activated Killer immune Cells, Saline)

    Recruiting
    • Malignant Pleural Effusion
    • Malignant Peritoneal Effusion
    • Virus Activated Killer immune Cells
    • Saline
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Sep 29, 2022

    AML Trial in Beijing (IM23)

    Completed
    • AML
    • Beijing, China
      Xian Lu
    Jan 18, 2023

    Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

    Recruiting
    • Non-Hodgkin Lymphoma
    • Relapsed/Refractory Diffuse Large B-cell Lymphoma
    • NKTR-255 at 1.5 µg/kg
    • +3 more
    • La Jolla, California
    • +26 more
    Jan 10, 2023

    B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • Autologous Anti-CD19 CAR-expressing T Lymphocytes
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Jan 30, 2023

    Metastatic Breast Cancer Trial in Seongnam (Nivolumab)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Seongnam, Korea, Republic of
      Seoul National University Bundang Hospital
    Sep 5, 2021

    NSCLC, Ovarian Cancer, Fallopian Tube Cancer Trial in United States (CART-TnMUC1, Cyclophosphamide, Fludarabine)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +5 more
    • CART-TnMUC1
    • +2 more
    • Phoenix, Arizona
    • +9 more
    Jul 18, 2022

    Prostate Cancer Trial in Little Rock (Blood draw)

    Completed
    Has Results
    • Prostate Cancer
    • Blood draw
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 15, 2021

    Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

    Not yet recruiting
    • Prostate Carcinoma
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2023

    Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

    Recruiting
    • Refractory Multiple Myeloma
    • Relapsed Multiple Myeloma
    • Manufactured Anti-BCMA CAR-T cells
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    B-cell Acute Lymphocytic Leukemia Trial in Suzhou (CD19 CAR-T cells)

    Recruiting
    • B-cell Acute Lymphocytic Leukemia
    • CD19 CAR-T cells
    • Suzhou, China
      The First Affiliated Hospital of Soochow University
    Jan 11, 2023

    Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP

    Completed
    Has Results
    • Prostate Specific Antigens
    • Prostate Neoplasms
    • T-cell receptor alternate reading frame protein (TARP) peptide vaccine
    • T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 15, 2022

    Glioblastoma Multiforme, Astrocytoma, Grade III, Anaplastic Ependymoma Trial in Chicago (biological, procedure, radiation)

    Terminated
    • Glioblastoma Multiforme
    • +4 more
    • Heat Shock Protein Peptide Complex-96 (HSPPC-96)
    • +2 more
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hospital of Chicago
    Jul 24, 2020

    Safety and Efficacy Trial in Suzhou (Chidamide)

    Recruiting
    • Safety and Efficacy
    • Suzhou, Jiangsu, China
      First Affiliated Hospital,Soochow University
    Nov 30, 2021

    Gastric Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting Claudin18.2)

    Recruiting
    • Gastric Cancer
    • Chimeric antigen receptor T cell preparation targeting Claudin18.2
    • Qingdao, Shandong, China
      The Affiliated Hospital of Qingdao University
    Jul 11, 2023